Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Recursion Pharmaceuticals Inc (RXRX) vs Tractor Supply Co (TSCO) Price & Performance

Recursion Pharmaceuticals IncTrade
Tractor Supply CoTrade

Price performance (Past 24H)

Key statistics

Recursion Pharmaceuticals Inc vs Tractor Supply Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.33 (market cap $1.78B), while Tractor Supply Co trades at $35.55 (market cap $18.05B). The key difference: Tractor Supply Co is far larger — about 10.1× Recursion Pharmaceuticals Inc's market cap, and Tractor Supply Co pays a 2.77% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

RXRXTSCO
Market Cap
$1.78B$18.05B
Sector
HealthConsumer Cyclical
52-Week High
$6.79$62.65
52-Week Low
$2.84$29.14
Enterprise Value
$1.30B$24.36B
Dividend Yield
2.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Recursion Pharmaceuticals Inc

RXRX trades at $3.22, up 1.26% today, with a neutral technical signal and bearish moving averages. The company reported a Q2 2026 EPS miss of -$0.25 versus -$0.24 expected, with revenue declining year-over-year. Financials show steep losses, including a net income margin of -961.97% in 2026, though cash flow from financing activities provides a runway through early 2028. Recent news highlights partnership progress with Genentech but notes competitive pressures and slow revenue growth.

Outlook remains speculative due to high cash burn and unproven commercial scalability, posing significant risk. Analyst consensus is mixed with 40% buy ratings, reflecting optimism for AI-driven drug discovery potential against persistent profitability challenges. Investment appeal hinges on pipeline milestones, but current fundamentals warrant caution.

Tractor Supply Co

TSCO trades at $34.56, up 1.38% today, with a bullish technical signal from moving averages but overbought RSI readings. Recent earnings misses and a lowered 2026 outlook reflect cyclical headwinds, though the stock remains supported by a 48% buy rating from analysts and a $36.29 consensus price target. Cash flow from operations remains strong at $1.64B for 2025, but net cash flow was negative due to investments and financing activities.

The outlook is mixed: valuation reset and insider buying signal confidence, but weak discretionary demand and cost pressures pose near-term risks. Long-term opportunities exist from digital growth and pet initiatives, yet investors face volatility from earnings uncertainty and macroeconomic sensitivity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX

About Tractor Supply Co

Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).

Read more on TSCO